November 6, 2018
Keytruda in Dano Health

Keytruda (Pambrolizumab) in Dano Health view

Keytruda (Pambrolizumab) in Dano Health view Pembrolizumab that formerly named MK-3475 and Lambrolizumab with trade name Keytruda is a humanized antibody used in cancer immunotherapy. It was approved for the treatment of melanoma, certain subsets […]
November 6, 2018
Rituxan in Dano Health

Rituxan (Rituximab)

Rituxan (Rituximab) in Dano Health view Rituximab with the trade name Rituxan is an oncology drug that interferes with the growth and spread of cancer cells […]